6th Medicon Valley Inhalation Symposium

Future Opportunities of Inhalation – Final Program

When: 11th–12th October 2017, 09.00–18.00, 09.00–13.00
Where: Medicon Village, Lund, Sweden

All presentations are in English.

Day 1 – Wednesday the 11th of October

08.30–09.00   Registration Symposium
09.00–09.15   Welcome to MVICs Symposium, MSc. Lars Asking, MVIC

Connected Health

Chairman: Dr. Orest Lastow

09.15–09.35   Making Sense of Inhaler Monitoring Technologies: Can they Improve Respiratory Outcomes?,  Dr. Joanne Peart, Revenio Consulting Ltd
09.35–09.55   Opportunities and Challenges with Connected Devices, Chris Nother and Conor Mulcahy, Nypro Healthcare

Formulation Development

Chairman: Dr. Jessica Elversson

09.55–10.25   Modelling of Dry Powders for Inhalation, Dr. Kyrre Thalberg, AstraZeneca

10.25–11.10   Coffee and Mingle

Formulation Development cont.

11.10–11.30   A New Carrier for DPI on Basis of Mannitol, Dr. Hans-Leonhard Ohrem, Merck
11.30–11.50   Assessment of in vitro Similarity for Tiotropium Dry Powder Inhalable Formulations by Advanced Techniques, Dr. Oliver Croad, Circassia Ltd
11.50–12.10   Process Development and Scale up of Pressurized Metered Dose Inhaler (pMDI) Production Processes, Dr. Mikael Bisrat, Recipharm AB

12.10–13.45   Lunch and Mingle

Pre-clinical and Tox

Chairman: Dr. Karin Svens

13.45–14.10   Controlled Aerosol ExposuresDr. Per Gerde, Inhalation Science
14.10–14.35   Lung Tissue Responses to Inhaled Particulate Substances, Dr. Hui Zhang, AstraZeneca
14.35–15.00   Mini-pigs Instead of Dogs in Inhaled Tox StudiesBSc. Vanessa Ross, Envigo

15.00–16.00   Coffee and Mingle

Clinical Assessments and Trials

Chairman: Dr. Bengt Särnstrand

16.00–16.25  Characterisation of Patients with COPD beyond FEV1Professor Per Wollmer, Skåne University Hospital
16.25–16.50  Questionnaire Assessment of Symptoms in Airway Diseases – an OverviewMD Lars-Göran Carlsson, AB Kamsaco/Skåne University Hospital
16.50–17.15  Regulatory Considerations on the Application of Objective Physiological Assessments, Bob Clay, Consultant, Drug Development and Regulatory Strategy

17.15–17.30   Close and Summary Day 1, MSc. Lars Asking, MVIC

17.45–18.30  Drink Reception

18.30   Conference Dinner

Day 2 – Thursday the 12th of October

Trends in Inhaled Delivery

Chairman: Dr. Anna Stenstam

09.00–09.25   Advanced Approaches to Traditional APIs: DPI Particle Engineering, Formulation and CharacterizationDrEunice Costa, Hovione
09.25–09.50   Trends in the Inhalation Space, Martin Ohrt and Henrik HarboeLiita Care
09.50–10.15   SEM-EDS and Raman Spectroscopy to Accelerate Generic Drug Applications, Dr. Julie Suman, Next Breath, a division of AptarGroup Inc.

10.15–11.00   Coffee and Mingle

New Opportunities and Regulatory

Chairman: Dr. Bo Olsson

11.00–11.20  Modelled Deposition in Human Throat ModelsProfessor Stavros Kassinos, University of Cyprus
11.20–11.45   In vitro Regulatory Aspects on Inhalation products with focus on Inhaled Drug Delivery, Dr. Cornelia Nopitsch-Mai, German Medical Products Agency, MPA
11.45–12.10   In vitro Equivalence for Generic Inhalation Products, Dr. Anna Hillgren, Swedish Medical Products Agency, MPA

12.10–12.20   Closing Symposium, MSc. Lars Asking, MVIC

12.20–13.10   Lunch and Mingle